Literature DB >> 18754763

Effects of zonisamide on isolated head tremor.

I-U Song1, J-S Kim, S-B Lee, S-Y Ryu, J-Y An, H-T Kim, Y-I Kim, K-S Lee.   

Abstract

BACKGROUND AND
PURPOSE: The medical treatment available for patients with essential tremor (ET) is often inadequate. Furthermore, the efficacy of the medical treatments currently available for patients with ET of cranial nerve areas is less satisfactory than that of the medical treatments available for patients with ET involving the upper extremities. This pilot study was performed to evaluate whether zonisamide (ZNS) is effective in the treatment of patients with isolated head tremor.
METHODS: All subjects with isolated head tremor were randomly treated with either ZNS or propranolol. After a washout period, the subjects were switched to the alternative drug.
RESULTS: ZNS was found to be more effective in the treatment of patients with isolated head tremor than propranolol. No severe adverse effects were reported with either ZNS or propranolol.
CONCLUSION: ZNS may be more useful than propranolol for the treatment of ET patients with head tremor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754763     DOI: 10.1111/j.1468-1331.2008.02296.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  11 in total

Review 1.  Essential tremor: from bedside to bench and back to bedside.

Authors:  Elan D Louis
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

Review 2.  T-type calcium channel as a new therapeutic target for tremor.

Authors:  Hideto Miwa; Tomoyoshi Kondo
Journal:  Cerebellum       Date:  2011-09       Impact factor: 3.847

3.  Familial aggregation of cranial tremor in familial essential tremor.

Authors:  Elan D Louis; Nora Hernandez; Lorraine N Clark; Ruth Ottman
Journal:  Neuroepidemiology       Date:  2013-05-25       Impact factor: 3.282

Review 4.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849

5.  When do essential tremor patients develop head tremor? Influences of age and duration and evidence of a biological clock.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

6.  Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia.

Authors:  Giulia Paparella; Gina Ferrazzano; Antonio Cannavacciuolo; Francesco Cogliati Dezza; Giovanni Fabbrini; Matteo Bologna; Alfredo Berardelli
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

7.  Use of antiepileptic drugs for hyperkinetic movement disorders.

Authors:  A Siniscalchi; L Gallelli; G De Sarro
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

8.  Treatment of Essential Tremor: Are there Issues We are Overlooking?

Authors:  Elan D Louis
Journal:  Front Neurol       Date:  2012-01-13       Impact factor: 4.003

Review 9.  Zonisamide for essential tremor.

Authors:  Elisa Bruno; Alessandra Nicoletti; Graziella Filippini; Graziella Quattrocchi; Carlo Colosimo; Mario Zappia
Journal:  Cochrane Database Syst Rev       Date:  2017-08-24

10.  Differences in Regional Glucose Metabolism of the Brain Measured with F-18-FDG-PET in Patients with Essential Tremor According to Their Response to Beta-Blockers.

Authors:  In-Uk Song; Sang-Won Ha; Young-Soon Yang; Yong-An Chung
Journal:  Korean J Radiol       Date:  2015-08-21       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.